Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 897518 | ISIN: US62855J1043 | Ticker-Symbol: MYD
Tradegate
20.11.24
18:57 Uhr
14,200 Euro
-0,400
-2,74 %
1-Jahres-Chart
MYRIAD GENETICS INC Chart 1 Jahr
5-Tage-Chart
MYRIAD GENETICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
14,40014,70012:45
14,40014,70012:39

Aktuelle News zur MYRIAD GENETICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MYRIAD GENETICS Aktie jetzt für 0€ handeln
MiMyriad Genetics, Inc.: Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina's Updated Comprehensive Gene Panel Assay, TruSight Oncology 500 v23
DiMyriad Genetics, Inc.: Myriad Genetics Announces Prequel Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy5
MoWhere Myriad Genetics Stands With Analysts3
14.11.MYGN Stock Might Gain From SneakPeek Availability in Retail Stores3
13.11.Myriad Genetics, Inc.: Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch92SALT LAKE CITY, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with increased access to prenatal...
► Artikel lesen
12.11.Myriad Genetics stock hits 52-week low at $16.6 amid market shifts3
08.11.MYGN Beats on Q3 Earnings and Revenues, Raises '24 EPS View1
08.11.MYRIAD GENETICS INC - 10-Q, Quarterly Report-
07.11.Myriad Genetics Inc. Q3 Earnings Summary243WASHINGTON (dpa-AFX) - Below are the earnings highlights for Myriad Genetics Inc. (MYGN):Earnings: -$22.1 million in Q3 vs. -$61.3 million in the same period last year. EPS: -$0.24 in Q3 vs....
► Artikel lesen
07.11.Myriad Genetics, Inc.: Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance35Highlights Third quarter revenue grew 11% year-over-year to $213 million, driven by Pharmacogenomics (34%) and Prenatal (10%) and progress on payor coverage and revenue cycle initiatives.Third quarter...
► Artikel lesen
07.11.MYRIAD GENETICS INC - 8-K, Current Report2
04.11.Myriad Genetics (NASDAQ:MYGN) Shares Down 4.6% - Here's Why15
04.11.Myriad Genetics holds stock target after UNH update13
04.11.Myriad Genetics, Inc.: Myriad Genetics Comments on UnitedHealthcare's Updated Medical Policy for Pharmacogenetic Testing5
01.11.Myriad Genetics plummets 20% as UnitedHealth changes GeneSight coverage20
31.10.Myriad Genetics (MYGN) to Release Earnings on Thursday17
30.10.Myriad Genetics, Inc.: Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 20246
18.10.Myriad Genetics Shares Fall Despite Partnership With jscreen9
16.10.Myriad Genetics enters into strategic partnership with jscreen1
16.10.Myriad Genetics, Inc.: Myriad Genetics and jscreen Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access8
Seite:  Weiter >>
89 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1